Literature DB >> 23084013

18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.

A M García Vicente1, A Soriano Castrejón, F Relea Calatayud, V Muñoz Madero, M J Molina Garrido, A A León Martín, J M Cordero García, J P Pilkington Woll, I Chacón López-Muñiz, A Palomar Muñoz.   

Abstract

AIM: To analyse the correlation between (18)F-FDG uptake assessed by PET/CT in locally advanced breast tumours and histopathological and immunohistochemical prognostic factors.
MATERIAL AND METHODS: Thirty-six women with breast cancer were prospectively evaluated. PET/CT was requested in the initial staging previous to adjuvant chemotherapy (multicentric study). All the patients underwent an (18)F-FDG PET/CT with a dual-time-point acquisition. Both examinations were evaluated qualitatively and semiquantitatively with calculation of SUVmax values in PET-1 (SUV-1) and in PET-2 (SUV-2) and the percentage variation of the standard uptake values (retention index) between PET-1 and PET-2. Clinical and metabolic stages were assessed according to TNM classification. The biological prognostic parameters, such as the steroid receptor status, p53 and c-erbB-2 expression, proliferation rate (Ki-67), and grading were determined from tissue of the primary tumour. Metabolic and biological parameters were correlated.
RESULTS: A positive relationship was found between semiquantitative metabolic parameters and biological parameters. SUV-1 and SUV-2 values did not show significant statistical correlation (p<.05) except for the clinical tumour size. About the biological parameters, retention index showed the best results with positive and significant relation (p<.05) with estrogen and progesterone receptor status and Ki-67. Isolated SUV values did not show significant relation to these parameters.
CONCLUSION: Retention index showed the best relation with biological parameters compared to isolated SUVmax values. These data suggest that SUV change over time is a prognostic marker.
Copyright © 2011 Elsevier España, S.L. and SEMNIM. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23084013     DOI: 10.1016/j.remn.2011.12.001

Source DB:  PubMed          Journal:  Rev Esp Med Nucl Imagen Mol        ISSN: 2253-654X            Impact factor:   1.359


  8 in total

1.  Early and delayed prediction of axillary lymph node neoadjuvant response by (18)F-FDG PET/CT in patients with locally advanced breast cancer.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Fernanda Relea Calatayud; María Del Mar Muñoz Sánchez; Miguel Ángel Cruz Mora; Germán Andrés Jiménez Londoño; Ruth Espinosa Aunión
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-18       Impact factor: 9.236

2.  Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.

Authors:  Ana María García Vicente; Angel Soriano Castrejón; Miguel Angel Cruz Mora; Ana González Ageitos; María del Mar Muñoz Sánchez; Alberto León Martín; Ruth Espinosa Aunión; Fernanda Relea Calatayud; Vicente Muñoz Madero; Ignacio Chacón López-Muñiz; Jose Manuel Cordero García; Germán Andrés Jiménez Londoño
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-09-28       Impact factor: 9.236

3.  Correlation between 18F-FDG Positron-Emission Tomography 18F-FDG Uptake Levels at Diagnosis and Histopathologic and Immunohistochemical Factors in Patients with Breast Cancer.

Authors:  Gamze Uğurluer; Sinan Yavuz; Züleyha Çalıkuşu; Ertuğrul Seyrek; Mustafa Kibar; Meltem Serin; Canan Ersöz; Orhan Demircan
Journal:  J Breast Health       Date:  2016-07-01

4.  Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer.

Authors:  Ana María García Vicente; Miguel Ángel Cruz Mora; Antonio Alberto León Martín; María Del Mar Muñoz Sánchez; Fernanda Relea Calatayud; Ober Van Gómez López; Ruth Espinosa Aunión; Ana Gonzalez Ageitos; Angel Soriano Castrejón
Journal:  Tumour Biol       Date:  2014-08-20

5.  Dual-Time 18F-FDG PET/CT Imaging in Initial Locoregional Staging of Breast Carcinoma: Comparison with Conventional Imaging and Pathological Prognostic Factors.

Authors:  Aynur Ozen; Serdar Altinay; Ozgul Ekmekcioglu; Ramazan Albayrak; Ali Muhammedoglu; Hakan Yigitbas; Eylem Bastug; Atilla Celik
Journal:  Indian J Surg       Date:  2016-04-23       Impact factor: 0.656

6.  Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.

Authors:  Shinsuke Sasada; Norio Masumoto; Eri Suzuki; Satoshi Sueoka; Noriko Goda; Keiko Kajitani; Akiko Emi; Takayuki Kadoya; Morihito Okada
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-01-16       Impact factor: 9.236

7.  Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.

Authors:  Ana María García Vicente; Ángel Soriano Castrejón; Alberto León Martín; Ignacio Chacón López-Muñiz; Vicente Muñoz Madero; María del Mar Muñoz Sánchez; Azahara Palomar Muñoz; Ruth Espinosa Aunión; Ana González Ageitos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-04-30       Impact factor: 9.236

8.  Considering the Relationship between Quantitative Parameters and Prognostic Factors in Breast Cancer: Can Mean Standardized Uptake Value be an Alternative to Maximum Standardized Uptake Value?

Authors:  Reyhan Köroğlu; İsmail Köksal; Fikri Selçuk Şimşek; Fatma Gezer; Ersoy Kekilli; Bülent Ünal
Journal:  World J Nucl Med       Date:  2017 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.